l.aguirre

TL2 · Catania

Contributes reviews on supplier material. Based in Catania.

Joined 2 October 2024 · last posted 1d · groups: newcomer-guides

83 posts, newest first. Showing up to 150.

What a certificate commits its issuer to Replied, post #114 · Analytics › COA interpretation · 27 Jul 2026 · 29 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Here for the analytics and not much else Replied, post #84 · Lounge › Introductions · 24 Jul 2026 · 26 likes Helpful, and short, which on this subject is harder than long.
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #116 · Sourcing › Independent verification · 23 Jul 2026 · 12 likes The lot identifier has to match across vial, certificate and invoice for any of this to mean anything. It is the floor and it is worth checking every time. One of those…
Follow-up: How compounding permissions changed when supply normalised Replied, post #45 · Sourcing › Regulatory · 20 Jul 2026 · 11 likes Saving this. It is the version I will quote when the question comes round again.
About the Mass spectrometry category Replied, post #8 · Analytics › Mass spectrometry · 16 Jul 2026 · 16 likes Taking post #7 at face value and following it one step further. Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #75 · Outcomes › Progress reports · 14 Jul 2026 · 7 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not. Happy to expand any of that if it is the…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #94 · Data & Tools › Datasets · 11 Jul 2026 · 0 likes On community side-effect dataset the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #19 · Evidence › Journal club · 6 Jul 2026 · 0 likes Where I would push back on the STEP 8 consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #20 · Compounds › Retatrutide · 1 Jul 2026 · 7 likes Post #18 put the caveat in the right place and I want to underline it. Renal and cardiovascular outcome data does not exist for this compound. Absence of a reported…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #103 · Evidence › Journal club · 1 Jul 2026 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Journal club: SUSTAIN 6 and its retinopathy signal Started this topic · Evidence › Journal club · 26 Jun 2026 · 0 likes On the subject in the title: Journal club: SUSTAIN 6 and its retinopathy signal Working notes rather than a conclusion. Reading SUSTAIN 6 ( N Engl J Med , 2016) for the…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #32 · Practice › Reconstitution · 25 Jun 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Second pass at: Cagrilintide molecular characteristics and analytical considerations Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 23 Jun 2026 · 14 likes Worth distinguishing the combination product from the two components bought separately and mixed. Those are different pharmaceutical objects and nothing published about…
An appeal that succeeded, with the letter structure — the long version Replied, post #124 · Access › Insurance & coverage · 19 Jun 2026 · 23 likes This is the first time the answer has come with its own limits attached. Appreciated.
Tracking a shortage from primary sources rather than rumour Replied, post #57 · Access › Shortages · 18 Jun 2026 · 11 likes Post #56 is the version of this I will quote in future. One addition. A shortage of one presentation is not a shortage of all of them, and the published notices are…
Hair shedding at month three: mechanism and time course — the long version Replied, post #29 · Practice › Side effects · 16 Jun 2026 · 1 like That is consistent with mine, for whatever one more account is worth.
Micronutrient adequacy at low total intake Replied, post #99 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 1 like The version of micronutrient adequacy that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
Comparing prices across jurisdictions without misleading yourself Replied, post #74 · Access › Pricing · 13 Jun 2026 · 10 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #76 · Practice › Storage & stability · 7 Jun 2026 · 0 likes What I can speak to on reconstituted is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Reference intervals: how they are constructed and why one in twenty flags Replied, post #110 · Clinical › Bloodwork · 6 Jun 2026 · 2 likes Bringing the actual numbers with intervals to an appointment is far more useful than describing them, and clinicians here consistently say so.
Injection volume, overload, and peak distortion Replied, post #34 · Analytics › HPLC & UHPLC · 4 Jun 2026 · 12 likes Confirming post #31 from a second method, which matters more than confirming it from a second person. Method validation is the demonstration that a method can separate…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #6 · Compounds › Secretagogues & GH axis · 18 May 2026 · 3 likes Two claims get bundled together under secretagogues and glucose tolerance and they need separating. The descriptive one — this is what was observed — is usually well…
Packaging that arrived damaged: documenting it properly Replied, post #10 · Sourcing › Logistics · 15 May 2026 · 0 likes Post #9 is right about the mechanism and I think understates the practical bit. Split shipments reduce single-point risk and increase the number of transits. Which…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #42 · Evidence › Preprints · 30 Apr 2026 · 8 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #88 · Clinical › Bloodwork · 28 Apr 2026 · 11 likes Post #85 is the version of this I will quote in future. One addition. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #47 · Practice › Reconstitution · 20 Apr 2026 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I would…
Coming back to: Measurement error in a self-reported exposure Started this topic · Evidence › Study critique · 17 Apr 2026 · 18 likes Measurement error in a self-reported exposure — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here…
Blind submission and why it changes minds — the long version Replied, post #16 · Sourcing › Independent verification · 9 Apr 2026 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed Blind submission, as opposed to read about it? The thread is long and I cannot tell.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #118 · Research Methods › N-of-1 designs · 29 Mar 2026 · 0 likes Practical answer on ABAB design, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
[2026 update] Composite endpoints and the component doing the work Replied, post #44 · Evidence › Trials · 26 Mar 2026 · 23 likes Saving this. It is the version I will quote when the question comes round again.
The lowest dose that does anything: is that a real question? Replied, post #37 · Practice › Dosing & titration · 3 Mar 2026 · 2 likes The version of lowest dose that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
The "under review" status pill and when a moderator applies it Replied, post #2 · Evidence › Preprints · 27 Feb 2026 · 2 likes The opening post describes the usual case. This is about the unusual one. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they…
A site rotation scheme that is easy enough to actually follow Replied, post #10 · Practice › Administration · 25 Feb 2026 · 2 likes Where I part company with post #8, and it is a narrow parting. Note the site alongside the dose. If a local reaction appears three weeks later you will want to know…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #19 · Analytics › Impurities & related substances · 22 Feb 2026 · 0 likes Answering the question post #17 raises rather than the one it answers. Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all. A…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #70 · Practice › Storage & stability · 22 Feb 2026 · 0 likes Post #67 answers the question as asked. The question underneath it is different. My experience of Storing lyophilised material long term contradicts the reply above. I…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #76 · Analytics › Impurities & related substances · 20 Feb 2026 · 18 likes Post #72 describes the usual case. This is about the unusual one. A methods point on rising related-substance rather than a substantive one: if the comparison is not…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #53 · Sourcing › Red flags · 17 Jan 2026 · 29 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Second pass at: Metformin co-administration and additive GI effects Replied, post #34 · Practice › Interactions · 16 Jan 2026 · 5 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
A partial dose because the pen emptied mid-injection Replied, post #120 · Practice › Administration · 11 Jan 2026 · 5 likes Post #117 is right about the mechanism and I think understates the practical bit. If someone has run partial dose because the pen properly I would rather read that than…
How to ask about something you suspect is a bad idea Replied, post #41 · Start Here › How to Ask · 5 Jan 2026 · 31 likes That reframing is the whole thing. The facts I already had.
Second pass at: Counter-ion content and its effect on measured mass Replied, post #3 · Analytics › Mass spectrometry · 1 Jan 2026 · 1 like The opening post put the caveat in the right place and I want to underline it. Calibration matters: a high-resolution instrument out of calibration can report mass with…
A parcel stationary at a customs facility for nine days Replied, post #14 · Sourcing › Logistics · 23 Dec 2025 · 6 likes Nobody has said the unglamorous part of parcel stationary yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Documentation that appears only after payment Replied, post #101 · Sourcing › Red flags · 9 Dec 2025 · 21 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
Tracking a preprint to publication: a worked example Replied, post #11 · Evidence › Preprints · 29 Nov 2025 · 12 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors. It is…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #63 · Compounds › Oral incretins · 27 Nov 2025 · 0 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
Research-use-only labelling: what it means and what it does not Replied, post #63 · Sourcing › Regulatory · 23 Nov 2025 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
Second pass at: Programming during a large energy deficit Replied, post #87 · Nutrition & Training › Resistance training · 18 Nov 2025 · 0 likes Narrowing post #86, because the general version has more than one answer. Adding a null result on Programming during a large energy. I looked, carefully, and found…
Substitution between formats during a shortage Replied, post #98 · Access › Shortages · 18 Nov 2025 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #70 · Analytics › COA interpretation · 13 Nov 2025 · 21 likes Post #68 is the version of this I will quote in future. One addition. An itemised related-substances table with retention times says considerably more about the…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #13 · Compounds › Tirzepatide · 7 Nov 2025 · 29 likes Adding the measurement that post #10 says would settle it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more…
A 40-week log with the measurement method stated Replied, post #76 · Outcomes › Progress reports · 26 Oct 2025 · 2 likes The thing about 40-week log that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Documentation that appears only after payment Replied, post #47 · Sourcing › Red flags · 12 Oct 2025 · 17 likes That is consistent with mine, for whatever one more account is worth.
Discussing something you have already been doing Replied, post #12 · Clinical › Prescriber conversations · 3 Oct 2025 · 17 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Managing an unplanned gap in supply — what changed since Replied, post #77 · Access › Shortages · 2 Oct 2025 · 0 likes Adding the boring version of Managing an unplanned gap, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #38 · Evidence › Preprints · 28 Sep 2025 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
Thyroid function tests during substantial weight change Replied, post #63 · Clinical › Bloodwork · 16 Sep 2025 · 3 likes Post #62 is right about the mechanism and I think understates the practical bit. A note on scope: what I am saying about thyroid function tests during substantial…
[2026 update] Long-time reader, first-time poster Replied, post #9 · Lounge › Introductions · 6 Sep 2025 · 20 likes Having read the whole Long-time reader thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
Comparing two chromatograms from different laboratories, properly Replied, post #5 · Analytics › HPLC & UHPLC · 22 Aug 2025 · 24 likes Narrowing post #4, because the general version has more than one answer. On integration: where the baseline is drawn matters more than most people realise. On a clean…
Washout: how long is long enough, and for what purpose Replied, post #56 · Pharmacology › Pharmacokinetics · 16 Aug 2025 · 2 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
What a 2 ppm match establishes, and what it does not Replied, post #42 · Analytics › Mass spectrometry · 15 Aug 2025 · 9 likes Resolution: "high resolution" commonly means Someone should write this up properly, and it should probably not be me.
Travel coolers and how long they really hold Replied, post #40 · Devices › Cold chain · 4 Aug 2025 · 1 like The interaction between cold chain and the storage question is that a warm transit spends part of the material's stability budget before it reaches you, and the budget…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #149 · Compounds › Tirzepatide · 28 Jul 2025 · 0 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
[2026 update] US compounding rules and how they changed Replied, post #27 · Regional › North America · 25 Jul 2025 · 1 like The denial letter is the specification for the appeal. It states a criterion and the job is to demonstrate that criterion in the letter's own language. Old habit: I…
Pages past their review date, listed Replied, post #8 · Meta › Wiki maintenance · 20 Jul 2025 · 23 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity. It took me longer than it should have to see that.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #90 · Practice › Reconstitution · 20 Jul 2025 · 1 like Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
What a documentation review can and cannot tell you Replied, post #30 · Sourcing › Independent verification · 10 Jul 2025 · 2 likes Where I part company with post #29, and it is a narrow parting. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #26 · Practice › Dosing & titration · 29 Jun 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
Ipamorelin selectivity claims and where they came from Replied, post #46 · Compounds › Secretagogues & GH axis · 11 Jun 2025 · 0 likes Post #45 is right about the mechanism and I think understates the practical bit. Two things can be true about ipamorelin selectivity claims at once: the mechanism is…
Reading a trial's population section before its results — does this still hold? Replied, post #57 · Evidence › Trials · 1 May 2025 · 30 likes Picking up post #55: that is the part I would want checked first. The estimand: what the trial set out to estimate. Two trials can be identical in structure but…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #22 · Practice › Interactions · 22 Mar 2025 · 0 likes Post #18 and I disagree about the size of the effect, not about the direction. A pharmacist can answer most questions in this subcategory in a few minutes with access…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #13 · Compounds › Tirzepatide · 31 Jan 2025 · 21 likes I have been on both sides of the tirzepatide in type 2 diabetes argument in this category within eighteen months, which should tell you how strong the evidence for…
Fibre intake when total intake falls, and the constipation link Replied, post #21 · Nutrition & Training › Protein & intake · 26 Jan 2025 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Since fibre intake keeps coming up, it should probably be a maintained page rather…
What changed in 2026, by region Replied, post #60 · Access › International · 6 Jan 2025 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #123 · Clinical › Prescriber conversations · 15 Dec 2024 · 11 likes Post #119 put the caveat in the right place and I want to underline it. Bringing a record of symptoms with dates and severities makes an assessment materially easier…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #135 · Compounds › Other compounds · 22 Nov 2024 · 16 likes I think the Melanocortin agonists question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Converting between mg/mL and units per dose, both directions Replied, post #88 · Practice › Reconstitution · 14 Nov 2024 · 4 likes Answering the question post #86 raises rather than the one it answers. Preservative effectiveness is tested against a defined microbial challenge under defined…
[2026 update] New subcategory: rationale and scope Replied, post #4 · Meta › Announcements · 13 Nov 2024 · 30 likes What I would tell a new member reading about New subcategory for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Taste changes and food aversion, reported and discussed Replied, post #30 · Practice › Side effects · 17 Oct 2024 · 2 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #75 · Evidence › Journal club · 16 Oct 2024 · 26 likes That is consistent with mine, for whatever one more account is worth.
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #54 · Nutrition & Training › Hydration & electrolytes · 23 Aug 2024 · 13 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
High-resolution MS on aggregates and what it can see — one year on Replied, post #28 · Analytics › Mass spectrometry · 15 Aug 2024 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
Oral contraceptives and delayed emptying: what the data shows Replied, post #44 · Practice › Interactions · 14 Jul 2024 · 3 likes I had written a reply contradicting post #42 and deleted it. Here is what survived. Research-use-only compounds have no interaction data of any kind, because…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #134 · Practice › Dosing & titration · 10 Jul 2024 · 3 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…